1687.55 35.35 (2.14%)

3.9M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

Analyst Buy
Emkay retains its 'Buy' call on Sun Pharma, expects a revenue CAGR of 10.2% over FY25-27 See details

Detailed Stock Analysis for Sun Pharmaceutical Industries Ltd. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to GuruQ or StratQ
Subscribe Sign in